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Effect of Antibody Orientation on Immunosorbent
Performance
Anuradha Subramanian and William H. Velander*
ABSTRACT:
The impact of antibody orientation on immunosorbent efficiency was quantitatively assessed. A pH-dependent murine monoclonal
antibody (Mab) against human protein C (hPC), recombinant hPC (rhPC) and two different immobilization chemistries and matrices
were used as model systems. The lysyl groups of the rhPC were covalently modified with an acetic acid ester of Nhydroxysuccinimide and this modified rhPC was used as a Fab masking agent (FMA). The FMA was used to mask the antigen
binding regions (Fab) of the Mab prior to and during covalent immobilization. Thereafter, the residual active sites of the support were
inactivated and the FMA was removed. Mab was immobilizeed at low bead-averaged densities of about 0.4-1.1 mg Mab/mL matrix
to minimize local density effects. Immunosorbents made using masked Mab (oriented coupling) gave antigen binding efficiencies
(nAgo) f 4248% compared with 18-22% for those made by random coupling. The amount of (Fab), released from pepsin digestion of
immuncsorbents was about --fold higher for matrices having been made with FMA-masked Mab relative to unmasked Mab. Thus,
the (Fab), accessibility to pepsin correlates well with higher functional efficiency (nAJ and serves as a measure of orientation. In
summary, at low Mab density and a 2:l molar rhPC to Mab binding stoichiometry, about 80% or more of the Mab randomly coupled
through amino moieties was improperly oriented relative to oriented coupled Mab, which correlated with about 50% of lost Mab
functionality upon immobilization.
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Introduction
Immunoaffinity-based methods can be used as an
efficient and high-resolution step for protein purification
(Ta
r nowsky and Liptak, 1983; Tarnowsky et al., 1986). The
customized avidity of the parent antibody for a given
target molecule can make immunoaffinity chromatography
a versatile tool for purifiying closely related proteins in a
biologically active form (Orthner et al., 1989; Velander et
al., 1989). However, the use of immunosorbents on a
large scale is frequently precluded by high capital costs.
These costs can mostly be associated with the low
functional activity of immobilized antibodies and the
development and production costs of pathogen-free
antibody having a desired specificity for therapeutic
applications (Orthner et al., 1989; Velander et al., 1990).
Typically, antigen binding efficiencies of 3-15% are
obtained for monoclonal immunosorbents containing 1-10
mg of antibody/mL of support (Eveleigh
and Levy, 1977; Wilchek et al., 1984; Hearn, 1986; Strauss
et al., 1987; Subramanian et al., 1994). Immunoglobulins
(IgGs) are glycoproteins with an approximate molecular
weight of 150000Da. The nonantigen binding domain of
an IgG is known as the Fc region and has a cell receptor
function which is independent of the antigen binding
domain and function. IgGs have two identical disulfidelinked, antigen combining sites known as the Fab
domains which contain a highly variable sequence to
provide antigen binding specificity (Stryer, 1980). IgGs
can be enzymatically cleaved by pepsin to give an intact
(Fab), from the Fc domain (Stryer, 1980; Goding, 1983).
Author to whom correspondence should be addressed. The targeted
binding by protein A and G to the Fc domain has been
utilized to anchor Mabs (Schneider et al., 1982). The
variable avidity of protein A and G with different IgG

subclasses, protein leaching from the matrix and reagent
costs make this sandwich anchoring method less
amenable to large-scale applications. Alternatively, Fcspecific coupling chemistry which uses hydrazide-based
activation to oxydize carbohydrate on the Mab has been
developed (Hearn, 1986; O’Shanessey and Hoffmann,
1987; Little et al., 1988; Domen et al., 1990; Fleminger et
al., 1990; Bonde et al., 1991). However, carbohydrate also
occurs in the Fab domains and Mabs immobilized on
matrices using hydrazide chemistry did not produce
significant differences in Mab functional efficiency
compared with random immobilization by CNBr chemistry
(Orthner et al., 1991). The performance of an
immunosorbent is strongly dependent on intraparticle
transport, adsorption/desorption kinetics of the Mab
(Kaster et al., 1993) and on the molecular orientation
(Orthner et al., 1991; Velander et al.,
1992) and local density of the immobilized antibody
(Subramanian et al., 1994). It has long been hypothesized
that optimum binding kinetics for antigen binding requires
the right orientation and spacing of the immobilized
antibody (Velander et al., 1992). Although immunosorbent
efficiency is most often characterized on a volume or
bead averaged basis, antibody spacing can be a strong
function of position and a high local density greatly
decreases immunosorbent efficiency (Subramanian et al.,
1994). Multipoint attachment of the antibody to the support
matrix may also have a negative effect on immunosorbent
efficiency and about a 3-1 1-fold increase in
immunosorbent activity was observed for immobilized
Mabs having reactive NH.
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moieties protected by dimethylmaleic anhydride (Strauss
et
al., 1987; Hadas et al., 1990). We have previously
demonstrated that shielding of the Fab domains of Mabs
during the immobilization process results in greater
relative immunosorbent efficiency and Fab accessibility in
a membrane-based, enzyme-linked immunosorbent
assay (ELISA) system (Velander et al., 1992). In the
present study, we used a lysyl-modified recombinant
antigen to mask quantitatively the Mab prior to and during
immobilization to chromatographic matrices. Thus, the
FMA has been used here as a tool both to quantitatively
probe and to engineer Mab orientation in immunosorbents
used for purification.

Materials and Methods
Materials
A murine pH-dependent anti-hPC Mab (8861-Mab) was
provided by American Red Cross (Rockville, MD). Rabbit
antisera against hPC, affinity-purified goat-anti-mouse
(whole
molecule)
and
anti-goadanti-mouse
immunoglobulins conjugated to horseradish peroxidase
(HRP) were purchased from Sigma Chemical (St Louis,
MO). Goat antihPC antisera was purchased from
American Diagnostics (Greenwich, CT). Emphaze AB 1
biosupport medium was provided by 3M (Minneapolis,
MN) and Affiprep polymeric support was purchased from
Bio-Rad Laboratories (Anaheim, CA). Immulon I1
microtiter plates were purchased from Fisher Scientific
(Pittsburgh, PA). The hPC was provided by American Red
Cross. The rhPC was isolated from transgenic porcine
whey using immunoaffinity chromatography (Morcol et al.,
1994).

o-Phenylenediamine-dihydrochloride
(OPD) tablets were purchased from Abbott Laboratories
(Chicago, IL). The Nsuccinimide ester of acetic acid and
trinitrobenzenesulfonic acid (TNBS) were purchased from
Sigma Chemical. All other reagents were purchased from
Sigma Chemical as the best grade available.
Immunoaffinity separations were performed with
Phannacia C-10 columns (15 cmx 1 cm i.d.), a Masterflex
peristaltic pump and a Knauer spectrophotometer and a
Rainin data acquisition system were used to monitor
chromatography. Columns were kept at 4°C with a Lauda
Super RMT water cooler.
Synthesis of FMA from recombinant hPC
The reactive amino moieties on the rhPC were covalently
modified using an acetic acid ester of N-

hydroxysuccinimide (Endo et al., 1987). A 3 mg/mL
solution of rhpC in borate buffer (0.05 M borate, 0.14 M
NaCl, pH 8.6) was slowly mixed with 10 & of a 200 molar
excess of ester in dimethylformamide. The pH of the
reaction was maintained at 8.5 by the addition of 1 M
NaOH and the reaction was allowed to proceed for 24 h
at 4°C. The unreacted ester was quenched by adding a
40 molar excess of glycine using a 0.4 M glycine stock
solution at pH 8.5. After 4 h of stirring, the modified
protein solution was extensively dialyzed against
phosphate-buffered saline (PBS) (50 t n ~sod ium
phosphate, 100m NaCl, pH 7.0)’ for 24 h to yield a
protein-ester conjugate. The degree of modification of the
amino residues on rhPC was determined by TNBS assay
(Snyder and Sobocinski, 1975).

Preparation of unmasked and FMA-masked
Immunosorbent
Affi-prep is a polymeric support with reactive ester groups
which react with NH2 groups on proteins to give stable
amide linkages. Affi-prep was washed with 10 m~ sodium
acetate buffer (pH 4.5) according to the manufacturer’s
instructions and was suspended as a 50% (v/v) slurry in
the coupling buffer, 0.1 M MOPS, 0.15 M NaCl (pH 7.2).
Figure 1 shows the preparation of an rhPC-FMA-masked
immunosorbent. For the preparation of an FMA-masked
immunosorbent, each of two replicate support solutions
containing 1 mg of Mab was incubated with 2.4mg of
rhPC-FMA (6:l molar ratio) for 2 h at room temperature
(RT). In the case of the unmasked immunosorbent, Mab
was incubated with coupling buffer for the same period of
time.
The supernatant was pipetted from the top of the resin
and FMA-Mab solution was added to the tubes and the
slurry was rotated overnight at 4°C. Upon completion of
the coupling reaction, the gel was allowed to settle and
the supernatant was pipetted and saved for ELISA. The
residual active sites on the resin were blocked with 1.0 M
ethanolamine for 1 h at 4°C after which the supernatant
was drawn and saved €or ELISA. The gel was washed in
a column mode with 0.05 M Tris, 0.1 M NaCl (pH 7.0) until
the absorbance of the column effluent dropped to zero.
The FMA-Mab complex was disrupted with 2 M NaSCN.
The column was washed with all the buffer systems to be
employed in the actual chromatographic run and the
fractions were saved for Mab leakage determination. The
columns were stored in the protein coupling buffer at 4°C.
Emphaze AB 1 (dp=60 pm) is a polymer-based, rigid and
macroporous beaded affinity support for bioseparations
(Coleman et al., 1990). Emphaze AB 1 contains an
azlactone functionality which readily undergoes a ringopening reaction with amines to yield stable covalent

linkages. Mabs were immobilized on Emphaze AB1
according to the manufacturer’s instructions. Briefly, each
replicate treatment consisted of 125 mg of azlactone
beads suspended in 1.0 mL of coupling buffer containing
0.5 mg of 8861-Mab and 1.2 mg of rhPC-FMA (6: 1 molar
ratio) to yield 1 .O mL of affinity sorbent. On completion of
the Mab immobilization step, blocking and washing steps
similar to those described above were performed.

Determination of Mab bound

Figure 1.
Preparation of FMA-masked immunosorbent. Mab was incubated with
FMA in solution prior to covalent immobilization. FMA-Mab complexes
were then incubated with an activated matrix. Unreacted active sites on
the matrix were inactivated and the FMA was eluted from the Mab to
yield an oriented immobilized Mab.

Determination of protein C in feed and column eluates
The amount of rhPC antigen was determined by the
ELISA
procedure outlined by Subramanian et al. (1994).
Pepsin digestion of immobilized Mab

A 200pL of a 50% (v/v) slurry of FMA-masked or
unmasked immunosorbent was pipetted into screw-

The amounts of Mab in feed and coupling step
supernatants and washes were determined by the ELISA
procedure outlined by Subramanian et aZ., 1994).

Breakthrough Analysis
Breakthrough analysis of FMA-masked and unmasked
immunosorbents were performed according to the
procedure outlined by Subramanian et al. (1994). Each
column was subjected to three consecutive
chromatographic runs.

capped tubes in replicates to yield a final immunosorbent
volume of 100 pL. The immunosorbents were washed
four times with 0.1 M sodium citrate (pH 4.2) and
suspended in 100 pL of citrate buffer. A 10 pL volume of a
10 mg/mL solution of pepsin in 0.1 M acetate buffer (pH
4.5) was added to the reaction tubes and digestion was
carried out at 37°C for 5 h. Samples were taken at various
time intervals ranging from 0 to 360 min and digestion
was terminated with an addition of 12 pL of 1 M Trisbase.
The reaction mixture was centrifuged for 1Omin at 2000g
and the Supernatant was subjected to total (Fab),
determination. In a parallel experiment, pepsin-assisted
enzymatic digestion was carried out with solution-phase
Mab as a control (Johnstone and Thorpe (1987).
Determination of (Fab)2 in pepsin digest

Immulon I1 microtiter plates were coated with 100 pL per
well of 5 pg/mL diluted Fab specific murine antisera in 0.1
M NaHC03 (pH 9.3) for 24 h at 4°C. The wells were
washed with TBS (0.05 M Tris-O.1 M NaCl) 0.05% Tween
and the residual reactive sites were blocked with TBS-O.
1% polyethylene glycol (PEG) (MW 17 OOO) for 10 min
at RT. Various dilutions of (Fab), standard and
supernatants from pepsin digest in TBS-O.176 PEG were
added to the wells, Following incubation the wells were
washed four times and 1000-fold diluted HRP conjugated
goat-anti-mouse IgG was added to the wells and
incubated for 20 min at 37°C. 100 µL in each well, and
incubated for 20 min at 37°C. The wells were washed
four times and 100 pL of OPD substrate were added to
each well. The colorimetric reaction was stopped after 3-5
min by the addition of la0 pL of 1.5 M H2S04 to each well.
Bound chromophore was detected at 490nm using a BioTek EL308 microplate reader.

Results
Modification of the reactive primary amines
The number of available reactive primary amines on rhPC
were modified by covalent and irreversible reaction with
an ester. The extent of covalent modification was
determined by the ability of modified rhPC to react with
TNBS. The primary amines on proteins react with TNBS
to yield a TNBS-protein complex which absorbs at 420
nm and the absorbance is directly proportional to the
available reactive primary amines on the protein. Figure 2
shows the linear range of rhPC (native)-TNBS and
modified rhPC-TNBS assay signals. The extent of
modification was estimated from the ratio of the slopes of
the modified rhPC to that of rhPC (native). Thus, the
extent of covalent modification was estimated to be about
60+2%.

was immunopurified to 95% purity by randomly coupled
8861-Mab (Morcol et al., 1994). Figure 3 presents the
ELISA signal of immunosorbed rhPC-8861 -Mab (native or
modified) complex which had been first formed in solution
and then immunocaptured. In general, the ELISA signal of
unmodified rhPC- and hPC-8861-Mab complexes showed
Immobilization of Mab in the presence of FMA gave lower

Figure2. Reactivity of rhPC (native) and modified rhPC with TNBS. The
extent of modification of the amino residues on rhPC was determined
by TNBS assay (Velander et a/., 1992). Serial dilutions of native and
modified rhPC were incubated with 0.03 M TNBS for 30 min at RT.
Absorbances of the samples were read at 420 nm againt a reagent
blank (assay buffer alone). The percentage modification was
determined from the ratio of the slopes of the respective calibration
graphs.

similar increases with increasing antigen concentration.
The ELISA profile of the modified rhPC showed a slightly
higher signal than unmodified rhPC and hPC at antigen to
Mab molar stoichiometries of 1:l and 2:l. The profile was
otherwise similar for modified rhPC (FMA), rhPC and hPC
with a sharp maximum at a 6:l molar ratio of antigen to
Mab (Subramanian et al., 1994).
Effect of FMA on immobilization of Mab
Table 1 gives the coupling efficiencies obtained for
masked and unmasked immunosorbents using Affi-prep
or Emphaze AB1. Masking of the Mab was achieved with
FMA (modified rhPC). Prior to covalent immobilization,
FMA was incubated with 8861-Mab at a molar ratio of 6:l.

Antigen binding experiments
The relative binding stabilities of immunocomplexes
formed in solution from unmodified and modified rhPC
and native hPC from plasma with 8861-Mab were
screened by ELISA (Subramanian et al., 1994). The rhPC

Figure 3. Antigen binding experiments. Increasing concentrations of
hPC and rhPC were incubated with 8861-Mab at 1 h at 25°C and then
added to rabbit anti-hPC-coated wells. After 1 h of incubation at 37"C,
goat-anti-mouse IgG HRP conjugate was added to the wells and
incubated for 1 h. The hPC or rhPC- 8861-Mab complex was detected
and quantified with OPD and reading at 490 nm.

coupling efficiencies than Mab immobilized in the
absence of FMA on both Affiprep and Emphaze AB1
(Table 1). These masked Mabs were incubated at 2-3-fold
higher
concentrations to achieve similar average densities.
Immobilization of unmasked and masked 8861-Mab on
Affi-prep gave absolute Mab coupling efficiencies of 60-t

4% and 51 *3%, respectively, yielding 0.4 mg Mab/mL of
support. Immobilization of unmasked 8861-Mab on
Emphaze AB1 gave Mab coupling efficiencies of 9722%
and 94i3%,
yielding 0.5 and 1.0 mg Mab/mL of support, respectively.
Immobilization of masked 8861-Mab on Emphaze AB1
gave Mab coupling efficiencies of 6624% and 52i3%,
yielding 0.7 and 1.1 mg Mab/mL of support, respectively.
In the calculation of relative coupling efficiencies, a 100%
value was assigned to unmasked immunosorbents. Thus,
the presence of the FMA reduced the relative coupling
efficiency of the Mab by about 15% for Affi-prep and
3045% for Emphaze AB 1.

(Fab)2 Release by pepsin treatment of immunosorbents

Leaching of Mab
Prior to testing the immunosorbent capacity, three
proteinfree but otherwise identical sequences of buffers
used in the course of immunosorption chromatography
were passed columnwise and all buffer streams were
assayed for leached Mab and rhPC by EIAELISA. All
product peaks from immunosorbent chromatography were
assayed for leached Mab by EIA. Less than 0.3 ng
Mab/mg rhPC was detected in product eluates from
unmasked or masked, EMPHAZE AB1 or Affiprep
immunosorbents.
Antigen binding efficiency (qAJo f immobilized Mabs
Antigen binding efficiencies of 8861-Mab immobilized on
either Emphaze AB1 or Affiprep were evaluated by
breakthrough analysis. Figure 4 shows typical
breakthrough and elution profiles at 280nm for rhPC
loaded on both masked and unmasked 8861 -Mab
immunosorbent columns on either Emphaze AB1 or
Affiprep. The shapes of the breakthrough profiles and 2 M
naSCN elution peaks were similar for FMA-masked and
unmasked 8861-Mab immunosorbents. The peak area
under 2~ NaSCN eluate
fractions for FMA-masked immunosorbents were 2-3-fold
higher than those for immunosorbents made with
unmasked 8861-Mab at comparable Mab densities. The
Ag values of immobilized 8861-Mab on Emphaze ABl
and Affiprep based on the amount of antigen in the
product eluents from breakthrough loading are presented
in Table 2. Immobilization of unmasked and masked
8861-Mab on
Affiprep at 0.4 mg Mab/mL of gel gave Ag o f 18±3% and
48 2 5%, respectively. Immobilization of 'unmasked 8861Mab on Emphaze AB1 at 0.5 and 1.0 mg Mab/mL of
support gave (n,) of 2022% and 1923%, respectively.
Immobilization of masked 8861-Mab on Emphaze AB1 at
0.7 and 1.1 mg Mab/mL of support gave ( Ag) of 44±4%
and 42±5%, respectively.

Under acidic conditions, pepsin enzymatically cleaves an
intact IgG molecule at the hinge region to yield a (Fab),
and Fc fragment. Figure 5 represents the time-dependent
release of (Fab)2

presence of FMAs are consistent with an appreciable
stearic shielding of reactive lysyl groups on the Mab by
the FMA. The general inertness of the FMA was indicated
by both the nearly quantitative recovery of the treated
rhPC after immobilization and the lack of rhPC release
from matrix during subsequent conditioning washes,
which included harsh conditions such as 2 M NaSCN. The
stability of the Mab-matrix linkages formed from
unmasked and masked Mab was not appreciably different
as judged by the similarly minimal release of Mab from
either unmasked or masked immunosorbents into pastcoupling conditioning washes or product eluates. The
lower reactivity of the masked Mab may have allowed
greater permeation of the Mab into the matrix before
coupoling. Therefore, a greater spatial distribution of Mab
could have resulted throughout the matrix and thus
altered the intraparticle transport phenomena relative to
that of unmasked Mab. Analysis of rhPC breakthrough
curves on immunosorbents made with masked or
unmasked Mab

Figure 5. Enzymatic digestion of unmasked and FMA-masked
immunosorbents. 100 pL of immunosorbents in 0.1 M sodium

citrate (pH 4.2) were incubated at 37°C with 80 pg of pepsin.
Samples were taken at the time intervals indicated and
quenched with 1 M Tris base (pH 8.6). Supernatants were
assayed for total [Fabl by ELISA.

did not exhibit any discernible differences in the
breakthrough loading or elution profiles and thus mass
transport phenomena. Further, although we did not
directly investigate the intraparticle immobilization profile
resulting from masked Mab, our previous work with the
controlled
intraparticle distribution of unmasked Mab on Emphaze
AB 1 indicated that no significant mass transfer
differences occur for a broad range of intraparticle Mab
spatial
distributions at immobilized loadings of about 1-12 mg
Mab/mL matrix (Subramanian et al., 1994). The low bead
average density of Mab used here showed little impact on
( f)o r couplings with unmasked Mab and is consistent
with a density regime where Mab crowding is not a chief
cause of the loss of activity (Tharakan et al., 1990;
Velander et al., 1992; Subramanian et al., 1994).
However, it is possible that the presence of the
FMAshielding could also affect local Mab crowding under
conditions where the local Mab densities would be higher.
We are continuing to study these combined effects of
locally high Mab density and improper orientation. The
higher amount of (Fab),/mg immobilized Mab released by
pepsin treatment of immunosorbents prepared with
masked Mab relative to unmasked Mab correlated well
with the respective increases in ( Ag)B. oth Emphaze AB1
and Affiprep immunosorbents prepared using FMAmasked Mab gave a 2-3-fold higher ( Ag)a nd a 34fold
higher total pepsin-mediated (Fab), release relative to
immunosorbents prepared with unmasked Mab.
Furthermore, the similarity of the kinetic profiles of the
time-dependent release of (Fab), for either masked or
unmasked Mab is consistent with oriented Mab acting as
a pepsin substrate and independent of whether the
orientation resulted from a random or directed coupling
process. The similar adsorptiorddesorption kinetic

signatures detected by breakthrough antigen loading and
elution profiles between random and directed coupling
processes indicate that increases in ( Ag) re probably not
attributable to allosterically created conformations
resulting from the presence of the mask in the binding
sites of the (Fab), domain during coupling. This lack of
difference in kinetic signature shown in Fig. 3 includes
both antigen association under loading conditions and
dissocation under washing and elution conditions. In
terms of kinetics, the adsorption step of the
immunosorption process for the oriented antibody can be
interpreted as having a much larger association rate
relative to the unoriented Mab. Properly oriented Mab
may be found in either unmasked or masked produced
immunosorbents, but to a much lesser extent in
immunosorbents made from unmasked Mab. In summary,
the kinetics of the unoriented Mab appear to be so slow
as to be turned off relative to an oriented Mab, Estimation
of the sizes of FMAs studied in this and our past work
suggest that effective masks should approach the size of
the antigen combining site on the Fab fragment of an IgG
molecule. Our previous work with synthetic FMA showed
that larger masks of about 5-12kDa gave higher increases
in relative efficiency and a greater correlation with the
accessibility of Fab domains (Eveleigh and Levy, 1977).
Assuming similar globular behavior, the size of the Fab
domain on an IgG molecule (45kDa) and rhPC-FMA (62
ma) can be expected to be similar on a molecular level,
which is about 2-3 nm (Sarma el af., 1971; Novotny et al.,
1983).

Conclusions
Our exepriments have shown that a greater degree of
random coupling of the protein to the matrix occurs when
the Mab is unmasked and that oriented coupling occurs
when the Mab is masked with FMA. We have shown
quantitatively that orientation plays a primary role in
immunosorbent activity where orientation phenomena
may be impacting about 50% of the immobilized Mab
functionality. FMAs can be used to increase the
percentage of functional antibody relative to that obtained
using random
covalent attachment without altering the Mab or the
support matrix. The orientation phenomena achieved by
masking the immunoglobulin prior to immobilization
appear to be independent of the surface activation
chemistry and support matrix.
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